Pathos AI's proprietary software platform Foundry has access to approximately 200 petabytes of oncological data to generate and test hypotheses on disease biology.

From the articlePathos AI teams up with Bristol Myers and Tempus AI to advance drug development | ReutersAlso in AI drug development startup Pathos AI closes $237M investment - SiliconANGLE